Monolithisch India to Boost Purulia Plant Capacity with Capex-I Expansion

1 min read     Updated on 17 Sept 2025, 12:59 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
whatsapptwittershare
Overview

Monolithisch India is expanding its Purulia plant, with the Capex-I project set to begin operations on October 2, 2025. This expansion will increase the plant's annual production capacity to 206,000 tonnes per annum for ramming mass products. The move aims to meet growing market demand and potentially improve the company's market position in the sector.

19639770

*this image is generated using AI for illustrative purposes only.

Monolithisch India has announced a significant expansion of its Purulia plant, set to enhance the company's production capabilities in the ramming mass products sector. The expansion, dubbed Capex-I, is scheduled to commence operations on October 2, 2025.

Capacity Boost

The Capex-I project at the Purulia facility is designed to substantially increase the plant's production capacity. Upon completion, the plant's annual output is expected to reach 206,000.00 tonnes per annum (TPA), marking a notable uplift in Monolithisch India's manufacturing capabilities.

Meeting Market Demand

This strategic expansion comes in response to the growing demand for ramming mass products. Ramming masses are crucial materials used in various industries, particularly in the production of refractories and in metallurgical processes. The increased capacity is likely to position Monolithisch India to better serve its customers and potentially capture a larger market share in this sector.

Strategic Timing

With the expansion set to go live on October 2, 2025, Monolithisch India demonstrates a forward-looking approach to its business operations. This proactive step in expanding production capacity suggests the company's confidence in the continued growth of the ramming mass market and its ability to meet future demand.

Implications for Stakeholders

For investors and industry watchers, this expansion signals Monolithisch India's commitment to growth and its responsiveness to market trends. The increased production capacity could potentially lead to improved revenues and market position, subject to prevailing market conditions and demand at the time of the expansion's completion.

As the project progresses towards its 2025 launch date, stakeholders will likely keep a close eye on its development and any updates from Monolithisch India regarding the expected impact of this expansion on the company's overall performance and market strategy.

Historical Stock Returns for Monolithisch

1 Day5 Days1 Month6 Months1 Year5 Years
+3.07%-1.38%+19.15%+93.13%+93.13%+93.13%
Monolithisch
View in Depthredirect
like18
dislike

Mukul Agrawal's Monolithisch India Soars 200% in 44 Days, Portfolio Gains Momentum

1 min read     Updated on 01 Sept 2025, 12:49 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Ace investor Mukul Agrawal's recent addition, Monolithisch India, has surged nearly 200% in 44 days since its June 19 listing on NSE's SME platform. It's now the second-best performer in Agrawal's portfolio of 64 stocks, worth over Rs 7,506 crore. Other notable performers include Yatharth Hospital (67% returns) and Tatva Chintan Pharma Chem (53% returns). Agrawal increased his stake in Prakash Industries to 1.70%, reduced holdings in five stocks, and potentially exited two. While many picks show strong performance, 18 holdings have negative returns up to 30%.

18256746

*this image is generated using AI for illustrative purposes only.

Ace investor Mukul Agrawal's recent addition to his portfolio, Monolithisch India , has delivered an impressive performance, surging nearly 200% in just 44 days since its listing on June 19. The stock, which made its debut on NSE's SME platform following its June IPO, has emerged as the second-best performer in Agrawal's diverse portfolio.

Portfolio Highlights

Agrawal's investment strategy continues to yield positive results, with his portfolio showing significant gains in the June quarter. Here's a breakdown of his recent investments and their performance:

Company Returns Agrawal's Stake
Monolithisch India 200.00% in 44 days 2.30%
Yatharth Hospital 67.00% since addition 1.10%
Tatva Chintan Pharma Chem 53.00% since addition 1.30%

Portfolio Overview

Mukul Agrawal's investment portfolio now consists of 64 stocks, with a net worth exceeding Rs 7,506.00 crore. The portfolio has shown robust growth, increasing by over 10% since June. In addition to the top performers, five other stocks picked in June have delivered returns ranging between 8% and 16%.

Portfolio Adjustments

During the quarter, Agrawal made several strategic moves:

  • Increased stake in Prakash Industries to 1.70%
  • Reduced holdings in five stocks
  • Potentially exited positions in two stocks

Performance Spectrum

While many of Agrawal's picks have shown strong performance, it's worth noting that not all investments have yielded positive returns:

  • 18 out of 64 holdings have delivered negative returns
  • The range of negative returns is up to 30%

Investor Insight

Mukul Agrawal's investment approach demonstrates a mix of high-growth small and mid-cap stocks, with a particular focus on the SME segment. The success of Monolithisch India on the NSE SME platform highlights the potential of this market segment for discerning investors.

The diverse performance across his portfolio underscores the importance of a balanced investment strategy, even for seasoned investors. While some picks like Monolithisch India have delivered exceptional returns, the presence of underperforming stocks in the portfolio reflects the inherent risks and volatility in equity investments.

As the market continues to evolve, investors will be watching closely to see how Agrawal's portfolio strategy adapts to changing economic conditions and emerging opportunities in the Indian stock market.

Historical Stock Returns for Monolithisch

1 Day5 Days1 Month6 Months1 Year5 Years
+3.07%-1.38%+19.15%+93.13%+93.13%+93.13%
Monolithisch
View in Depthredirect
like19
dislike
Explore Other Articles
469.50
+14.00
(+3.07%)